Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphomaGregory A Wiseman, Thomas E WitzigCancer|June 14, 2006
Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapyTerry E Justice, James A Martenson, Gregory A Wiseman, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 10, 2013
Outcome prediction in heart failure with atrial fibrillation: relative role of left ventricular ejection fraction and neurohormonal measuresIan P Clements, Gregory A Wiseman, David O Hodge, et al.Pediatric Transplantation|January 26, 2005
Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemiaVilmarie Rodriguez, Linda Erlandson, Carola A S Arndt, et al.World Journal of Nuclear Medicine|April 14, 2021
18F-fluorodeoxyglucose positron emission tomography/computed tomography of giant cell arteritis with lower extremity involvement in association with polymyalgia rheumaticaAnanya Panda, Gregory A Wiseman, Matthew J Koster, et al.Journal of Computer Assisted Tomography|September 27, 2007
Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CTDimitrios Karantanis, Rathan M Subramaniam, Brian P Mullan, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Additional radiation absorbed dose estimates for Zevalin radioimmunotherapyGregory A Wiseman, Bryan R Leigh, William L Dunn, et al.Journal of Vascular and Interventional Radiology : JVIR|October 31, 2009
Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinomaChad J Fleming, James C Andrews, Gregory A Wiseman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphomaStephen M Ansell, Kay M Ristow, Thomas M Habermann, et al.The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancerVahab Fatourechi, Ian D Hay, Houman Javedan, et al.Pageof 6